Company Filing History:
Years Active: 2004-2020
Title: Innovations in Cancer Treatment by Zhuoru Liu
Introduction
Zhuoru Liu is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research. He holds 4 patents that focus on innovative methods for diagnosing and treating various types of cancer. His work is particularly notable for its potential to improve patient outcomes in challenging cancer cases.
Latest Patents
One of Zhuoru Liu's latest patents involves the diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand. This invention relates to methods that utilize the expression of ILT3 ligand or ILT3 on specific cancer cells as a diagnostic tool. The patent outlines methods for treating ILT3-ligand expressing cancers, such as T-cell acute lymphoblastic leukemia. For instance, it describes administering ILT3, the extracellular domain of ILT3, or ILT3Fc conjugated to a cytotoxic agent to effectively target and kill cancer cells. Additionally, the patent provides methods for treating cancers that express ILT3 on their surface, including monocytic forms of acute myeloid leukemia (AML), by administering anti-ILT3 antibodies conjugated to a cytotoxic agent.
Career Highlights
Zhuoru Liu is affiliated with Columbia University, where he conducts research and develops innovative solutions in the field of cancer treatment. His work has garnered attention for its potential to revolutionize how certain cancers are diagnosed and treated.
Collaborations
Zhuoru Liu collaborates with esteemed colleagues, including Nicole Suciu-Foca and Chih-Chao Chang, to advance research in cancer therapies. Their combined expertise contributes to the development of groundbreaking methods that could significantly impact patient care.
Conclusion
Zhuoru Liu's innovative work in cancer treatment exemplifies the potential of scientific research to transform healthcare. His patents and collaborations highlight the importance of continued innovation in the fight against cancer.